IGF1 and hepatocellular carcinoma: Hyperinsulinemia, a characteristic feature of insulin resistance, stimulates both the insulin and insulin-like growth factor-1 (IGF-1) signaling pathways, which are closely associated with the development of HCC by promoting mitogenic activity, suppressing apoptosis, and disrupting normal cell proliferation (31).